Skip to main content

3rd International Workshop Insulin & Cancer: Heidelberg, October 30th-31st, 2010

  1. Adipokines, e.g. TNFα, IL-6 and leptin increase insulin resistance, and consequent hyperinsulinaemia influences breast cancer progression. Beside its mitogenic effects, insulin may influence adipokine producti...

    Authors: Jean Grisouard, Kaethi Dembinski, Doris Mayer, Ulrich Keller, Beat Müller and Mirjam Christ-Crain
    Citation: Diabetology & Metabolic Syndrome 2011 3:16
  2. A large prospective study in patients with type 2 diabetes (T2D), the German D2C cohort, is presently being enumerated to investigate risk factors of incident cancer in diabetic patients.

    Authors: Hans-Werner Hense, Hiltraud Kajüter, Jürgen Wellmann and Wolf U Batzler
    Citation: Diabetology & Metabolic Syndrome 2011 3:15
  3. Insulin analogues are increasingly considered as an alternative to human insulin in the therapy of diabetes mellitus. Insulin analogues (IAs) are chemically different from human insulin and may have different ...

    Authors: Harald G Enzmann and Martina Weise
    Citation: Diabetology & Metabolic Syndrome 2011 3:14
  4. In order to provide comprehensive information on the differences in bioactivity between human insulin and insulin analogues, published in vitro comparisons of human insulin and the rapid acting analogues insulin ...

    Authors: Haim Werner and Ernst A Chantelau
    Citation: Diabetology & Metabolic Syndrome 2011 3:13
  5. There is a well established link between obesity and cancer. Emerging research is characterising this relationship further and delineating the specific role of excess visceral adiposity, as opposed to simple o...

    Authors: Claire L Donohoe, Suzanne L Doyle and John V Reynolds
    Citation: Diabetology & Metabolic Syndrome 2011 3:12
  6. Either endogenous or exogenous hyperinsulinemia in the setting of insulin resistance promotes phosphorylation and activation of farnesyltransferase, a ubiquitous enzyme that farnesylates Ras protein. Increased...

    Authors: Boris Draznin
    Citation: Diabetology & Metabolic Syndrome 2011 3:10